메뉴 건너뛰기




Volumn 22, Issue 2 B, 2002, Pages 1083-1089

Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC

Author keywords

Neuron specific enolase (NSE); Small cell lung cancer (SCLC); Therapy monitoring

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; NEURON SPECIFIC ENOLASE; TUMOR MARKER;

EID: 0036329329     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (21)

References (27)
  • 6
    • 0031786615 scopus 로고    scopus 로고
    • Analytical performance of the new single step COBAS Core NSE EIA II and its diagnostic utility in comparison with the established COBAS Core NSE EIA
    • (1998) Clin Lab , vol.44 , pp. 871-879
    • Ebert, W.1    Muley, Th.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.